CJC-1295 (Without DAC) is a modified growth hormone-releasing hormone (GHRH) analogue widely studied for its ability to stimulate the body’s natural release of growth hormone through activation of GHRH receptors. Unlike the DAC version, CJC-1295 Without DAC has a significantly shorter half-life, making it a preferred growth hormone research peptide for studies requiring more controlled dosing protocols and physiological pulsatile hormone release. CJC-1295 Without DAC research continues to investigate its role in endocrine function, metabolism, and growth hormone regulation.
Current CJC-1295 Without DAC peptide research has explored its potential influence on endogenous growth hormone secretion, insulin-like growth factor-1 (IGF-1) production, protein synthesis, and metabolic function. Numerous CJC-1295 Without DAC studies have examined its interaction with the pituitary gland and its effects on hormone signaling pathways involved in body composition, recovery, muscle physiology, and healthy aging. Researchers continue to evaluate CJC-1295 Without DAC for its pharmacokinetic profile, receptor activity, and biological mechanisms as part of ongoing endocrine and metabolic research.
As interest in peptide-based hormone research continues to grow, CJC-1295 Without DAC peptide remains an important investigational compound in scientific studies focused on growth hormone physiology, metabolism, and performance-related research. Ongoing preclinical and clinical investigations continue to expand the understanding of CJC-1295 Without DAC, its mechanisms of action, and its potential applications in growth hormone research.
CJC-1295 (Without DAC) is intended for laboratory and scientific research purposes only. This investigational research peptide is not approved for human consumption or therapeutic use.
$55.00
Select products include third-party testing for added quality transparency.
Review available certificate of analysis documentation before ordering.
Orders are packaged with privacy, security, and presentation in mind.
Checkout is designed to be simple, private, and easy to complete.
CJC-1295 (Without DAC) is a modified growth hormone-releasing hormone (GHRH) analogue widely studied for its ability to stimulate the body’s natural release of growth hormone through activation of GHRH receptors. Unlike the DAC version, CJC-1295 Without DAC has a significantly shorter half-life, making it a preferred growth hormone research peptide for studies requiring more controlled dosing protocols and physiological pulsatile hormone release. CJC-1295 Without DAC research continues to investigate its role in endocrine function, metabolism, and growth hormone regulation.
Current CJC-1295 Without DAC peptide research has explored its potential influence on endogenous growth hormone secretion, insulin-like growth factor-1 (IGF-1) production, protein synthesis, and metabolic function. Numerous CJC-1295 Without DAC studies have examined its interaction with the pituitary gland and its effects on hormone signaling pathways involved in body composition, recovery, muscle physiology, and healthy aging. Researchers continue to evaluate CJC-1295 Without DAC for its pharmacokinetic profile, receptor activity, and biological mechanisms as part of ongoing endocrine and metabolic research.
As interest in peptide-based hormone research continues to grow, CJC-1295 Without DAC peptide remains an important investigational compound in scientific studies focused on growth hormone physiology, metabolism, and performance-related research. Ongoing preclinical and clinical investigations continue to expand the understanding of CJC-1295 Without DAC, its mechanisms of action, and its potential applications in growth hormone research.
CJC-1295 (Without DAC) is intended for laboratory and scientific research purposes only. This investigational research peptide is not approved for human consumption or therapeutic use.
| Vial Size | 10mg |
|---|
— Documentation-First Quality
CJC w/out DAC — Batch Documentation
Product
CJC-1295 (Without DAC) is a modified growth hormone-releasing hormone (GHRH) analogue widely studied for its ability to stimulate the body’s natural release of growth hormone through activation of GHRH receptors. Unlike the DAC version, CJC-1295 Without DAC has a significantly shorter half-life, making it a preferred growth hormone research peptide for studies requiring more controlled dosing protocols and physiological pulsatile hormone release. CJC-1295 Without DAC research continues to investigate its role in endocrine function, metabolism, and growth hormone regulation.
Current CJC-1295 Without DAC peptide research has explored its potential influence on endogenous growth hormone secretion, insulin-like growth factor-1 (IGF-1) production, protein synthesis, and metabolic function. Numerous CJC-1295 Without DAC studies have examined its interaction with the pituitary gland and its effects on hormone signaling pathways involved in body composition, recovery, muscle physiology, and healthy aging. Researchers continue to evaluate CJC-1295 Without DAC for its pharmacokinetic profile, receptor activity, and biological mechanisms as part of ongoing endocrine and metabolic research.
As interest in peptide-based hormone research continues to grow, CJC-1295 Without DAC peptide remains an important investigational compound in scientific studies focused on growth hormone physiology, metabolism, and performance-related research. Ongoing preclinical and clinical investigations continue to expand the understanding of CJC-1295 Without DAC, its mechanisms of action, and its potential applications in growth hormone research.
CJC-1295 (Without DAC) is intended for laboratory and scientific research purposes only. This investigational research peptide is not approved for human consumption or therapeutic use.
— How Ordering works
Explore our Catalog
Check product info
Secure your order
— What To Expect —
— Explore the Catalog
— Customer Experience
Common Questions
For optimal performance, lyophilized peptides should be reconstituted with bacteriostatic water (BAC water) using sterile handling techniques. Introduce the solution slowly along the inner wall of the vial, allowing it to gently combine with the peptide powder. Avoid shaking, as delicate peptide structures are best preserved through gentle swirling or natural dissolution.
Once fully reconstituted, the solution should appear clear and free of visible particles. The amount of BAC water used may vary based on your preferred concentration, with 1–2 mL per vial being the most common preparation.
Proper storage is essential to maintaining peptide stability and quality. Unreconstituted peptides are best preserved at -20°C for long-term storage or 2–8°C for short-term refrigeration. After reconstitution, peptides should be stored at 2–8°C and used within 4–6 weeks for optimal integrity.
To protect the quality of your peptides, keep them shielded from direct light and avoid repeated freeze-thaw cycles. Reconstituted peptides should never be frozen, as freezing may compromise their structural stability and performance.
$55.00
Reviews
There are no reviews yet.